Skip Navigation


ToxSci Advance Access originally published online on September 21, 2005
Toxicological Sciences 2005 88(2):514-524; doi:10.1093/toxsci/kfi331
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
88/2/514    most recent
kfi331v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Warheit, D. B.
Right arrow Articles by Reed, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warheit, D. B.
Right arrow Articles by Reed, K. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Comparative Pulmonary Toxicity Inhalation and Instillation Studies with Different TiO2 Particle Formulations: Impact of Surface Treatments on Particle Toxicity

D. B. Warheit1, W. J. Brock2, K. P. Lee3, T. R. Webb and K. L. Reed

DuPont Haskell Laboratory for Health and Environmental Sciences, Newark, Delaware

Received July 12, 2005; accepted September 14, 2005

Most pigment-grade titanium dioxide (TiO2) samples that have been tested in pulmonary toxicity tests have been of a generic variety—i.e., generally either uncoated particles or TiO2 particles containing slightly hydrophilic surface treatments/coatings (i.e., base TiO2). The objectives of these studies were to assess in rats, the pulmonary toxicity of inhaled or intratracheally instilled TiO2 particle formulations with various surface treatments, ranging from 0–6% alumina (Al2O3) or alumina and 0–11% amorphous silica (SiO2). The pulmonary effects induced by TiO2 particles with different surface treatments were compared to reference base TiO2 particles and controls. In the first study, groups of rats were exposed to high exposure (dose) concentrations of TiO2 particle formulations for 4 weeks at aerosol concentrations ranging from 1130–1300 mg/m3 and lung tissues were evaluated by histopathology immediately after exposure, as well as at 2 weeks and 3, 6, and 12 months postexposure. In the second study, groups of rats were intratracheally instilled with nearly identical TiO2 particle formulations (when compared to the inhalation study) at doses of 2 and 10 mg/kg. Subsequently, the lungs of saline-instilled and TiO2-exposed rats were assessed using both bronchoalveolar (BAL) biomarkers and by histopathology/cell proliferation assessment of lung tissues at 24 h, 1 week, 1 and 3 months postexposure. The results from these studies demonstrated that for both inhalation and instillation, only the TiO2 particle formulations with the largest components of both alumina and amorphous silica surface treatments produced mildly adverse pulmonary effects when compared to the base reference control particles. In summary, two major conclusions can be drawn from these studies: (1) surface treatments can influence the toxicity of TiO2 particles in the lung; and (2) the intratracheal instillation-derived, pulmonary bioassay studies represent an effective preliminary screening tool for inhalation studies with the identical particle-types used in this study.

Key Words: titanium dioxide particles; pulmonary toxicity; surface treatments on particles; particle coatings.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Toxicol PatholHome page
M. Yokohira, T. Kuno, K. Yamakawa, K. Hosokawa, Y. Matsuda, N. Hashimoto, S. Suzuki, K. Saoo, and K. Imaida
Lung Toxicity of 16 Fine Particles on Intratracheal Instillation in a Bioassay Model Using F344 Male Rats
Toxicol Pathol, June 1, 2008; 36(4): 620 - 631.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
A. V. Fedulov, A. Leme, Z. Yang, M. Dahl, R. Lim, T. J. Mariani, and L. Kobzik
Pulmonary Exposure to Particles during Pregnancy Causes Increased Neonatal Asthma Susceptibility
Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 57 - 67.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
D. L. Costa, J. R. Lehmann, D. Winsett, J. Richards, A. D. Ledbetter, and K. L. Dreher
Comparative Pulmonary Toxicological Assessment of Oil Combustion Particles Following Inhalation or Instillation Exposure
Toxicol. Sci., May 1, 2006; 91(1): 237 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
K. W. Powers, S. C. Brown, V. B. Krishna, S. C. Wasdo, B. M. Moudgil, and S. M. Roberts
Research Strategies for Safety Evaluation of Nanomaterials. Part VI. Characterization of Nanoscale Particles for Toxicological Evaluation
Toxicol. Sci., April 1, 2006; 90(2): 296 - 303.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. S. Tsuji, A. D. Maynard, P. C. Howard, J. T. James, C.-w. Lam, D. B. Warheit, and A. B. Santamaria
Research Strategies for Safety Evaluation of Nanomaterials, Part IV: Risk Assessment of Nanoparticles
Toxicol. Sci., January 1, 2006; 89(1): 42 - 50.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.